8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Date of Report (Date of earliest event reported): August 9, 2010

MEDCATH CORPORATION

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization) 000-33009
(Commission File Number) 56-2248952
(IRS Employer Identification No.)

10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)

(704) 815-7700
(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition

On August 9, 2010, MedCath Corporation issued a press release announcing its results of operations for the fiscal quarter ended June 30, 2010. A copy of the press release and supplemental financial information are furnished as Exhibits 99.1 and 99.2, respectively.

Item 9.01. Financial Statements and Exhibits

Exhibit 99.1 Press Release dated August 9, 2010

Exhibit 99.2 Supplemental Financial Information

Exhibits 99.1 and 99.2 listed in this Item 9.01 are being furnished under Item 2.02 and shall not be deemed “filed” for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MEDCATH CORPORATION
Date: August 9, 2010	By:	/s/ James A. Parker
		James A. Parker
		Executive Vice President and Chief Financial Officer

INDEX TO EXHIBITS

Exhibit No.	Description
Exhibit 99.1	Press Release dated August 9, 2010
Exhibit 99.2	Supplemental Financial Information

EX-99.1

Exhibit 99.1

MEDCATH CONTACT:
O. Edwin French
President/Chief Executive Officer
(704) 815-7700  
Art Parker
Chief Financial Officer
(704) 815-7700

MEDCATH CORPORATION REPORTS THIRD QUARTER
FISCAL 2010 EARNINGS

     CHARLOTTE, N.C., Aug 9, 2010 – MedCath Corporation (Nasdaq: MDTH), a healthcare provider focused on high acuity healthcare services, today announced operating results for its third quarter of fiscal 2010, which ended June 30, 2010.

Highlights

• Net revenue of $131.8 million, up 5.8% compared to the third quarter of fiscal 2009.

• Total admissions increase of 15.4%, and adjusted admissions increase of 13.3%, compared to third quarter of fiscal 2009.

• Same facility hospital admissions up 6.9%, and same facility adjusted admissions up 2.8%, compared to the third quarter of fiscal 2009.

• Adjusted EBITDA of $10.2 million, excluding share based compensation and other items described below.

• Operating cash flow from continuing operations of $9.7 million.

• EPS from continuing operations of $(0.71) and Adjusted EPS from continuing operations of $0.05, excluding impairment expense, share-based compensation and other items described below.

     Commenting on the results, Ed French, MedCath’s president and chief executive officer, said, “This quarter we experienced strong patient volume growth and solid revenue growth as we benefited from both our diversification efforts and growth in many of our cardiovascular services. Our results have stabilized since the beginning of our fiscal year as the efforts made by our operating and hospital leadership are paying off.”

Third Quarter of Fiscal 2010 Results Compared to Third Quarter of Fiscal 2009 Results

     MedCath’s reported net revenue increased 5.8% to $131.8 million in the third quarter of fiscal 2010 compared to $124.6 million in the third quarter of fiscal 2009. Same facility net revenue for the third quarter of fiscal 2010, which excludes the results of Hualapai Mountain Medical Center, totaled $124.4 million compared to $124.6 million in the third quarter of fiscal 2009. Income from operations decreased to a loss of $(22.5) million in the third quarter of fiscal 2010 from $0.2 million in the third quarter of fiscal 2009. MedCath’s loss from continuing operations was $(14.2) million, or $(0.71) per diluted share, in the third quarter of fiscal 2010 compared to breakeven results in the third quarter of fiscal 2009.

     MedCath’s third quarter of fiscal 2010 financial results include the following items:

• $22.8 million, or $0.69 per diluted share, long-lived asset impairment charge;

• $1.7 million, or $0.05 per diluted share, of professional fees and other expenses incurred in connection with MedCath’s exploration of strategic alternatives announced on March 1, 2010; and

• $0.6 million, or $0.02 per diluted share, in share-based compensation expense.

     MedCath’s third quarter of fiscal 2009 financial results include the following items:

• $3.1 million, or $0.09 per diluted share, reduction in net revenue and Adjusted EBITDA related to the reduction in reimbursement from certain payors for prior years;

• $2.3 million, or $0.07 per diluted share, decrease in Adjusted EBITDA related to certain professional fees, severance expense and other unusual items described below which were incurred during that period;

• $0.8 million, or $0.02 per diluted share, in pre-opening expense; and

• $0.2 million, or $0.01 per diluted share, in share-based compensation expense.

     Excluding these items, Adjusted EBITDA was $10.2 million in the third quarter of fiscal 2010 compared to $12.9 million in the same period of the prior year. MedCath’s Adjusted EPS for the third quarter of fiscal 2010 was $0.05 compared to $0.19 in the third quarter of fiscal 2009.

Operating Statistics, Cash Flow and Capital Expenditures

     MedCath’s financial results for the third quarter ended June 30, 2010, reflect a 15.4% increase in total admissions and a 13.3% increase in adjusted admissions compared to the third quarter of fiscal 2009. Same facility hospital admissions in the third quarter of fiscal 2010 were 6,042, up 6.9% compared to the third quarter of fiscal 2009. Same facility hospital adjusted admissions totaled 8,837, up 2.8% compared to the third quarter of fiscal 2009. Same facility hospital outpatient cases totaled 14,347 in the third quarter of fiscal 2010, up 2.4% compared to the third quarter of fiscal 2009.

     Total uncompensated care, which includes charity care plus bad debt expense, equaled 12.1% of hospital division net patient revenue before the deduction for charity care in the third quarter of fiscal 2010 compared to 9.2% in the third quarter of fiscal 2009. The increase in uncompensated care during the third quarter of fiscal 2010 was primarily due to an increase in the self-pay portion of patients participating in commercial health plans in one of our markets.

     Net cash provided by operating activities from continuing operations for the third quarter of fiscal 2010 was $9.7 million compared to $13.6 million in the third quarter of fiscal 2009. Cash paid for capital expenditures during the third quarter of fiscal 2010 totaled $2.0 million.

Impairment and Other Expense

     In accordance with generally accepted accounting principles, MedCath evaluates whether or not the carrying values of long lived assets exceed their fair values whenever indications of impairment arise. The fair values of long lived assets were determined by a review of current and anticipated operating performance and outlook, and market-based information obtained as a result of MedCath’s evaluation of its strategic alternatives. As the review of strategic alternatives is on-going, MedCath will continue to evaluate the carrying value of its long lived assets when and if new indications of impairment exist. Any gain due to the fair value of our assets exceeding their carrying value cannot be recorded until the disposition of those assets occurs. MedCath’s third quarter of fiscal 2010 results include a $22.8 million non-cash impairment charge related to the reduction in the carrying value of long-lived assets associated with one hospital. The impairment charge reduced income from continuing operations by $22.8 million and earnings per diluted share by $0.69 in the third quarter of fiscal 2010.

Update on Strategic Alternatives

     On March 1, 2010, MedCath announced it was exploring strategic alternatives such as selling individual assets or the entire Company. On August 9, 2010, MedCath announced that Arizona Heart Hospital, LLC, owned 70.6% by MedCath and 29.4% by physician investors has entered into an Asset Purchase Agreement with Vanguard Health Systems. The announcement of this agreement is the first such transaction since MedCath began exploring its strategic alternatives to maximize shareholder value. The transaction is expected to close during MedCath’s first quarter of fiscal 2011, which ends on December 31, 2010, subject to certain closing conditions.

Use of Non-GAAP Financial Measures

     Included in this press release and the supplemental financial information furnished herewith are certain financial measures that are not calculated and presented in conformity with generally accepted accounting principles (“non-GAAP measures”), such as adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”) and adjusted diluted earnings per share from continuing operations (“Adjusted EPS”). Adjusted EBITDA represents MedCath’s (loss) income from continuing operations before interest expense; loss on early extinguishment of debt; income tax (benefit) expense; depreciation; amortization; stock-based compensation expense; loss(gain) on disposal of property, equipment and other assets; interest and other income; equity in net earnings of unconsolidated affiliates; net income attributable to noncontrolling interests; impairment of property and equipment, loss on note receivable, DSH adjustments, Medicare reimbursement charges, professional fees from internal assessment in the case of the third fiscal quarter of 2009 and professional fees associated with MedCath’s exploration of strategic alternatives in the case of the third quarter of fiscal 2010 and pre-opening expenses. Adjusted EPS represents MedCath’s diluted (loss) earnings per share from continuing operations for the third fiscal quarter ended June 30, 2010 adjusted for share-based compensation expense,

loss on early extinguishment of debt, impairment of property and equipment, loss on note receivable, professional fees associated with MedCath’s consideration of strategic alternatives, DSH adjustments, Medicare reimbursement charges, professional fees from internal assessment and pre-opening expenses. MedCath’s management uses Adjusted EBITDA to measure the performance of MedCath’s various operating entities, to compare actual results to historical and budgeted results and to make capital allocation decisions. Management provides Adjusted EBITDA and Adjusted EPS to investors to assist them in performing their analyses of MedCath’s historical operating results. Further, management believes that many investors in MedCath also invest in, or have knowledge of, other healthcare companies that use Adjusted EBITDA and/or Adjusted EPS as a financial performance measure. Because Adjusted EBITDA and Adjusted EPS are non-GAAP measures, Adjusted EBITDA and Adjusted EPS, as defined above, may not be comparable to other similarly titled measures of other companies. MedCath has included a supplemental schedule with the financial statements that accompanies this press release that reconciles historical Adjusted EBITDA to MedCath’s income from continuing operations and Adjusted EPS to diluted EPS from continuing operations.

     This press release and the financial information included therewith will be accessible on the web, by going to www.medcath.com, “Investor Relations,” then clicking on “News.”

     MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates ten hospitals with a total of 825 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

# # #

     Parts of this announcement contain forward-looking statements that involve risks and uncertainties, including those relating to MedCath’s exploration of strategic alternatives. Although management believes that these forward-looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control including, but not limited to, enactment of changes in federal law that would limit physician hospital ownership. Actual results could differ materially from those projected in these forward-looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy. The preparation of MedCath’s third quarter of fiscal 2010 operating results required management to make estimates and assumptions that affect reported amounts of revenues and expenses. There is a reasonable possibility that actual results may vary significantly from those estimates.

     These various risks and uncertainties are described in detail in “Risk Factors” in MedCath’s Annual Report or Form 10-K for the year ended September 30, 2009 filed with the Securities and Exchange Commission on December 14, 2009, as updated in our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2010 and our subsequent filings with the Securities and Exchange Commission. Copies of our filings with the Securities and Exchange Commission, including exhibits, are available at http://www.sec.gov.

EX-99.2

Exhibit 99.2

MEDCATH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

	Three Months Ended June 30,						Nine Months Ended June 30,
	2010			2009			2010			2009
Net revenue	$	131,847		$	124,588		$	390,815		$	381,410
Operating expenses:
Personnel expense		44,546			43,854			136,055			131,884
Medical supplies expense		35,706			36,472			107,453			105,829
Bad debt expense		13,642			10,406			36,241			28,798
Other operating expenses		29,935			26,537			89,292			81,039
Pre-opening expenses		—			754			866			1,340
Depreciation		7,636			6,466			23,054			19,179
Amortization		8			8			24			24
Impairment of property and equipment		22,813			—			42,761			—
Loss (gain) on disposal of property, equipment and other assets		20			(54	)		39			127
Total operating expenses		154,306			124,443			435,785			368,220
(Loss) Income from operations		(22,459	)		145			(44,970	)		13,190
Other income (expenses):
Interest expense		(1,131	)		(396	)		(3,337	)		(3,074	)
Loss on early extinguishment of debt		—			—			—			(6,702	)
Interest and other income		62			48			156			220
Loss on note receivable		—			—			(1,507	)		—
Equity in net earnings of unconsolidated affiliates		2,262			2,265			6,870			7,044
Total other income (expense), net		1,193			1,917			2,182			(2,512	)
(Loss) income from continuing operations before income taxes		(21,266	)		2,062			(42,788	)		10,678
Income tax (benefit) expense		(8,642	)		171			(17,929	)		1,287
Income (loss) from continuing operations		(12,624	)		1,891			(24,859	)		9,391
Income from discontinued operations, net of taxes		2,163			878			3,895			8,793
Net (loss) income		(10,461	)		2,769			(20,964	)		18,184
Less: Net income attributable to noncontrolling interest		(2,355	)		(2,273	)		(5,718	)		(9,860	)
Net (loss) income attributable to MedCath Corporation	$	(12,816	)	$	496		$	(26,682	)	$	8,324
Amounts attributable to MedCath Corporation common stockholders:
(Loss) income from continuing operations, net of taxes	$	(14,155	)	$	23		$	(29,246	)	$	1,708
Income from discontinued operations, net of taxes		1,339			473			2,564			6,616
Net (loss) income	$	(12,816	)	$	496		$	(26,682	)	$	8,324
(Loss) earnings per share, basic
(Loss) income from continuing operations attributable to MedCath Corporation common stockholders	$	(0.71	)	$	—		$	(1.48	)	$	0.09
Income from discontinued operations attributable to MedCath Corporation common stockholders		0.07			0.03			0.13			0.33
(Loss) earnings per share, basic	$	(0.64	)	$	0.03		$	(1.35	)	$	0.42
(Loss) earnings per share, diluted
(Loss) income from continuing operations attributable to MedCath Corporation common stockholders	$	(0.71	)	$	—		$	(1.48	)	$	0.09
Income from discontinued operations attributable to MedCath Corporation common stockholders		0.07			0.03			0.13			0.33
(Loss) earnings per share, diluted	$	(0.64	)	$	0.03		$	(1.35	)	$	0.42
Weighted average number of shares, basic		19,897			19,733			19,823			19,665
Dilutive effect of stock options and restricted stock		—			—			—			56
Weighted average number of shares, diluted		19,897			19,733			19,823			19,721

MEDCATH CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

	June 30,			September 30,
	2010			2009
	(Unaudited)
Current assets:
Cash and cash equivalents	$	27,396		$	31,883
Accounts receivable, net		61,230			58,913
Income tax receivable		1,192			—
Medical supplies		15,888			15,459
Deferred income tax assets		12,272			12,161
Prepaid expenses and other current assets		13,711			13,471
Current assets of discontinued operations		26,172			44,978
Total current assets		157,861			176,865
Property and equipment, net		289,861			341,394
Investments in affiliates		10,301			14,055
Other assets		7,460			10,785
Deferred income tax assets		603			—
Non-current assets of discontinued operations		46,741			47,349
Total assets	$	512,827		$	590,448
Current liabilities:
Accounts payable	$	27,559		$	35,920
Income tax payable		—			297
Accrued compensation and benefits		17,148			16,118
Other accrued liabilities		20,647			23,277
Current portion of long-term debt and obligations under capital leases		15,808			21,187
Current liabilities of discontinued operations		19,062			19,832
Total current liabilities		100,224			116,631
Long-term debt		56,250			66,563
Obligations under capital leases		7,459			4,596
Deferred income tax liabilities		—			13,874
Other long-term obligations		5,262			8,533
Long-term liabilities of discontinued operations		35,872			35,721
Total liabilities		205,067			245,918
Commitments and contingencies
Redeemable noncontrolling interest		6,095			7,448
Stockholders’ equity:
Preferred stock, $0.01 par value, 10,000,000 shares authorized; none issued		—			—
Common stock, $0.01 par value, 50,000,000 shares authorized; 22,446,727 issued and 20,492,366 outstanding at June 30, 2010; 22,104,917 issued and 20,150,556 outstanding at September 30, 2009		216			216
Paid-in capital		457,058			455,259
Accumulated deficit		(118,102	)		(91,420	)
Accumulated other comprehensive loss		(395	)		(360	)
Treasury stock, at cost; 1,954,361 shares at March 31, 2010 1,954,361 shares at September 30, 2009		(44,797	)		(44,797	)
Total MedCath Corporation stockholders’ equity		293,980			318,898
Noncontrolling interest		7,685			18,184
Total equity		301,665			337,082
Total liabilities and equity	$	512,827		$	590,448

MEDCATH CORPORATION
SELECTED OPERATING DATA
(In thousands, except per share data and selected operating data)
(Unaudited)

	Three Months Ended June 30,								Nine Months Ended June 30,
	2010			2009		% Change			2010			2009		% Change
Statement of Operations Data:
Net revenue	$	131,847		$	124,588		5.8	%	$	390,815		$	381,410		2.5	%
Adjusted EBITDA (1)	$	10,238		$	12,920		(20.8	)%	$	25,820		$	41,298		(37.5	)%
(Loss) Income from operations	$	(22,459	)	$	145		(15589.0	)%	$	(44,970	)	$	13,190		(440.9	)%
(Loss) income from continuing operations, net of taxes	$	(14,155	)	$	23		(61643.5	)%	$	(29,246	)	$	1,708		(1812.3	)%
(Loss) income per share from continuing operations, basic	$	(0.71	)	$	—		(100.0	)%	$	(1.48	)	$	0.09		(1744.4	)%
(Loss) income per share from continuing operations, diluted	$	(0.71	)	$	—		(100.0	)%	$	(1.48	)	$	0.09		(1744.4	)%

(1) See Supplemental Financial Disclosure-Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.

	Three Months Ended June 30,															Nine Months Ended June 30,
										2010															2010
	2010			2009			% Change			Same Facility			% Change			2010			2009			% Change			Same Facility			% Change
Selected Operating Data (a):
Number of hospitals		7			6						6						7			6						6
Licensed beds ( c )		600			530						530						600			530						530
Staffed and available beds ( d )		514			484						444						514			484						444
Admissions ( e )		6,526			5,653			15.4	%		6,042			6.9	%		19,347			17,883			8.2	%		18,176			1.6	%
Adjusted admissions ( f )		9,741			8,594			13.3	%		8,837			2.8	%		28,436			25,621			11.0	%		26,252			2.5	%
Patient days ( g )		24,276			22,795			6.5	%		22,582			(0.9	)%		72,536			69,841			3.9	%		68,073			(2.5	)%
Adjusted patient days ( h )		36,474			34,803			4.8	%		33,284			(4.4	)%		107,012			100,167			6.8	%		98,809			(1.4	)%
Average length of stay (days) ( i )		3.72			4.03			(7.7	)%		3.74			(7.2	)%		3.75			3.91			(4.1	)%		3.75			(4.1	)%
Occupancy ( j )		51.9	%		51.8	%					55.9	%					51.7	%		52.9	%					56.2	%
Inpatient catheterization procedures ( k )		2,971			2,735			8.6	%		2,903			6.1	%		8,824			8,993			(1.9	)%		8,624			(4.1	)%
Inpatient surgical procedures ( l )		1,865			1,809			3.1	%		1,769			(2.2	)%		5,463			5,394			1.3	%		5,237			(2.9	)%
Hospital net revenue	$	127,613		$	118,104			8.1	%	$	120,148			1.7	%	$	377,402		$	363,790			3.7	%	$	358,086			(1.6	)%
Combined Operating Data (b):
Number of hospitals		9			8						8						9			8						8
Licensed beds ( c )		767			697						697						767			697						697
Staffed and available beds ( d )		678			647						608						678			647						608
Admissions ( e )		9,079			8,521			6.5	%		8,595			0.9	%		27,143			26,683			1.7	%		25,972			(2.7	)%
Adjusted admissions ( f )		13,993			13,288			5.3	%		13,089			(1.5	)%		41,528			39,751			4.5	%		39,344			(1.0	)%
Patient days ( g )		32,365			31,192			3.8	%		30,671			(1.7	)%		97,344			96,503			0.9	%		92,881			(3.8	)%
Adjusted patient days ( h )		49,970			48,428			3.2	%		46,780			(3.4	)%		148,184			142,436			4.0	%		139,981			(1.7	)%
Average length of stay (days) ( i )		3.56			3.66			(2.7	)%		3.57			(2.5	)%		3.59			3.62			(0.8	)%		3.58			(1.1	)%
Occupancy ( j )		52.5	%		53.0	%					55.4	%					52.6	%		54.6	%					56.0	%
Inpatient catheterization procedures ( k )		3,663			3,450			6.2	%		3,595			4.2	%		10,928			11,347			(3.7	)%		10,728			(5.5	)%
Inpatient surgical procedures ( l )		2,480			2,381			4.2	%		2,384			0.1	%		7,177			7,211			(0.5	)%		6,951			(3.6	)%
Hospital net revenue	$	170,658		$	158,497			7.7	%	$	163,193			3.0	%	$	502,693		$	485,882			3.5	%	$	483,377			(0.5	)%

(a)	Selected operating data includes consolidated hospitals in operation as of the end of the period reported in continuing operations but does not include hospitals which are accounted for using the equity method or as discontinued operations in our consolidated financial statements. Same facility for the three and nine months ended June 30, 2010 exclude the results of Hualapai Mountain Medical Center.
(b)	Combined operating data includes hospitals in operation as of the end of the period reported in continuing operations including hospitals which are accounted for using the equity method in our consolidated financial statements.
(c)	Licensed beds represent the number of beds for which the appropriate state agency licenses a facility regardless of whether the beds are actually available for patient use.
(d)	Staffed and available beds represent the number of beds that are readily available for patient use at the end of the period.
(e)	Admissions represent the number of patients admitted for inpatient treatment.
(f)	Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by admissions.
(g)	Patient days represent the total number of days of care provided to inpatients.
(h)	Adjusted patient days is a general measure of combined inpatient and outpatient volume. We computed adjusted patient days by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by patient days.
(i)	Average length of stay (days) represents the average number of days inpatients stay in our hospitals.
(j)	We computed occupancy by dividing patient days by the number of days in the period and then dividing the quotient by the number of staffed and available beds.
(k)	Inpatients with a catheterization procedure represent the number of inpatients with a procedure performed in one of the hospitals’ catheterization labs during the period.
(l)	Inpatient surgical procedures represent the number of surgical procedures performed on inpatients during the period.

MEDCATH CORPORATION
SUPPLEMENTAL FINANCIAL DISCLOSURE — RECONCILIATION OF GAAP FINANCIAL MEASURES
TO NON-GAAP FINANCIAL MEASURES
(Unaudited)

The following table reconciles the loss from continuing operations, net of taxes attributable to MedCath Corporation’s common stockholders as derived directly from MedCath Corporation’s consolidated financial statements to Adjusted EBITDA for the three and nine months ended June 30, 2010 and 2009.

	Three Months Ended June 30,						Nine Months Ended June 30,
	2010			2009			2010			2009
	(in thousands)						(in thousands)
(Loss) income from continuing operations, net of taxes	$	(14,155	)	$	23		$	(29,246	)	$	1,708
Add:
Income tax (benefit) expense		(8,642	)		171			(17,929	)		1,287
Net income attributable to noncontrolling interest		1,531			1,868			4,387			7,683
Equity in net earnings of unconsolidated affiliates		(2,262	)		(2,265	)		(6,870	)		(7,044	)
Interest and other income		(62	)		(48	)		(156	)		(220	)
Loss on note receivable		—			—			1,507			—
Loss on early extinguishment of debt		—			—			—			6,702
Interest expense		1,131			396			3,337			3,074
Loss (gain) on disposal of property, equipment and other assets		20			(54	)		39			127
Impairment of property and equipment		22,813			—			42,761			—
Amortization		8			8			24			24
Depreciation		7,636			6,466			23,054			19,179
Pre-opening expenses		—			754			866			1,340
Share-based compensation expense		553			231			2,379			2,068
Professional fees for strategic plans		1,667			—			1,667			—
DSH and Medicaid adjustments		—			3,064			—			3,064
Professional fees for internal assessment		—			1,106			—			1,106
Settlement of Medicare claims		—			840			—			840
Severance expense		—			360			—			360
Adjusted EBITDA	$	10,238		$	12,920		$	25,820		$	41,298

The following table reconciles MedCath Corporation’s diluted (loss) earnings per share from continuing operations, net of taxes attributable to MedCath Corporations common stockholders as derived directly from MedCath’s consolidated financial statements to Adjusted diluted (loss) earnings per share from continuing operations for the three and nine months ended June 30, 2010 and 2009.

	Three Months Ended June 30,					Nine Months Ended June 30,
	2010			2009		2010			2009
Diluted (loss) earnings per share	$	(0.71	)	$	—	$	(1.48	)	$	0.09
Add:
Impairment of property and equipment		0.69			—		1.23			—
Loss on note receivable		—			—		0.05			—
DSH and Medicaid adjustments		—			0.09		—			0.09
Professional fees for internal assessment		—			0.03		—			0.03
Professional fees for strategic plans		0.05			—		0.05			—
Settlement of Medicare claims		—			0.03		—			0.03
Severance expense		—			0.01		—			0.01
Loss on early extinguishment of debt		—			—		—			0.22
Share-based compensation expense		0.02			0.01		0.08			0.07
Pre-opening expense		—			0.02		0.02			0.04
Adjusted diluted earnings (loss) per share	$	0.05		$	0.19	$	(0.05	)	$	0.58